+1 (704) 266-3234

Global Human Microbiome Market

Published on: Dec 2018 | From USD $3950 | Published By: VERIFIED MARKET RESEARCH | Number Of Pages: 142

The global Human MicrobiomeMarketwas valued at USD 160.57 million in 2016 and is projected to reach USD 899.40million by 2025, growing at a CAGR of 21.10% from 2017 to 2025.
The human microbiota or microbiome is the aggregate of microorganisms that resides on or within any of a number of human tissues and biofluids, including the skin, mammary glands, placenta, seminal fluid etc.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Increased Focus on Human Microbiome Therapy
1.2 Human Microbiome as New Validated Target for Drug Development
1.3 Human Microbiome for Early Disease Detection and Diagnosis

2. Market Restraints
2.1 Lack of Expertise
2.2 Barriers in Proving the Causal Link Between Dysbiosis and Disease

Market Segmentation:
1. Global Human MicrobiomeMarket, by Product:
1.1 Instruments
1.1.1 Laboratory Instruments
1.1.2 Analyzers
1.2 Consumables
1.2.1 Kits
1.2.2 Reagents

2. Global Human MicrobiomeMarket, by Technology:
2.1 Cell Culture Technology
2.2 High-Throughput Technology
2.3 Omics Technology
2.4 Computational Tools

3. Global Human MicrobiomeMarket, by Disease:
3.1 Acute Diarrhea
3.2 Obesity
3.3 Diabetes
3.4 Autoimmune Disorders
3.5 Cancer
3.6 Mental Disorders
3.7 Other Diseases

4. Global Human Microbiome Market, by Application:
4.1 Therapeutics
4.2 Diagnostics

5. Global Human Microbiome Market, by Product type:
5.1 Probiotics
5.2 Foods
5.3 Prebiotics
5.4 Medical Foods
5.5 Diagnostic Devices
5.6 Drugs
5.7 Other Probiotic Supplements

6. Global Human Microbiome Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Enterome Bioscience
2. E.I. Du Pont De Nemours and Company
3. Merck & Co., Inc.
4. Metabiomics Corporation
5. Yakult Honsha Co., Ltd.
6. Microbiome Therapeutics, LLC
7. Osel, Inc.
8. Second Genome, Inc.
9. Vithera Pharmaceuticals
10. Vedanta Biosciences, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH:
Research study on the Human MicrobiomeMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the research methodology of verified market research and other aspects of the research study, kindly get in touch with our sales team.

1 INTRODUCTION OF GLOBAL HUMAN MICROBIOMEMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL HUMAN MICROBIOMEMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT
5.1 Instruments
5.1.1 Laboratory Instruments
5.1.2 Analyzers
5.2 Consumables
5.2.1 Kits
5.2.2 Reagents

6 GLOBAL HUMAN MICROBIOME MARKET, BY TECHNOLOGY
6.1 Cell Culture Technology
6.2 High-Throughput Technology
6.3 Omics Technology
6.4 Computational Tools

7 GLOBAL HUMAN MICROBIOME MARKET, BY DISEASE
7.1 Acute Diarrhea
7.2 Obesity
7.3 Diabetes
7.4 Autoimmune Disorders
7.5 Cancer
7.6 Mental Disorders
7.7 Other Diseases

8 GLOBAL HUMAN MICROBIOME MARKET, BY APPLICATION
8.1 Therapeutics
8.2 Diagnostics

9 GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT TYPE
9.1 Probiotics
9.2 Foods
9.3 Prebiotics
9.4 Medical Foods
9.5 Diagnostic Devices
9.6 Drugs
9.7 Other Probiotic Supplements
10 GLOBAL HUMAN MICROBIOMEMARKET, BY GEOGRAPHY
10.1 Overview
10.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 – 2025

11 GLOBAL HUMAN MICROBIOMEMARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies

12 COMPANY PROFILES
12.1 Enterome Bioscience
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments

12.2 E.I. Du Pont De Nemours and Company
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments

12.3 Merck & Co., Inc.
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments

12.4 Metabiomics Corporation
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments

12.5 Yakult Honsha Co., Ltd.
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments

12.6 Microbiome Therapeutics, LLC
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments

12.7 Osel, Inc.
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments

12.8 Second Genome, Inc.
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments

12.9 Vithera Pharmaceuticals
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments

12.10 Vedanta Biosciences, Inc.
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments

13 Appendix
13.1 Related Reports

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3950
USD $4750
USD $6750
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.